Dipòsit Digital de Documents de la UAB
Publicación
Artículo científico (JournalArticle)
Mass spectrometry vs immunofixation for treatment monitoring in multiple myeloma
Monitoring of the monoclonal protein (M-protein) by electrophoresis and/or immunofixation (IFE) has long been used to assess treatment response in multiple myeloma (MM). However, with the use of highly effective therapies, the M-protein becomes frequently undetectable, and more sensitive methods had to be explored. We applied IFE and mass spectrometry (EXENT&FLC-MS) in serum samples from newly diagnosed MM patients enrolled in the PETHEMA/GEM2012MENOS65 obtained at baseline (n 5 223), and after induction (n 5 183), autologous stem cell transplantation (n 5 173), and consolidation (n 5 173). At baseline, the isotypes identified with both methods fully matched in 82.1% of samples; in the rest but 2 cases, EXENT&FLC-MS provided additional information to IFE with regards to the M-protein(s). Overall, the results of EXENT&FLC-MS and IFE were concordant in.80% of cases, being most discordances due to EXENT&FLC-MS but IFE cases. After consolidation, IFE was not able to discriminate 2 cohorts with different median progression-free survival (PFS), but EXENT&FLC-MS did so; furthermore, among IFE patients, EXENT&FLC-MS identified 2 groups with significantly different median PFS (P 5.0008). In conclusion, compared with IFE, EXENT&FLC-MS is more sensitive to detect the M-protein of patients with MM, both at baseline and during treatment, and provides a more accurate prediction of patients' outcome. This trial was registered at www.clinicaltrials.gov as #NCT01916252.
Proyecto:
Ministerio de Economía y Competitividad CB16/12/00369
,
Ministerio de Economía y Competitividad CB16/12/00400
,
Ministerio de Economía y Competitividad CB16/12/00233
,
Ministerio de Economía y Competitividad CB16/12/00284
,
Ministerio de Economía y Competitividad PI15/01956
,
Instituto de Salud Carlos III PI18/01709
,
Instituto de Salud Carlos III PI18/01673
,
Instituto de Salud Carlos III PI19/01451
,
Ministerio de Economía y Competitividad PI15/02049
,
Ministerio de Economía y Competitividad PI15/02062
HANDLE: https://ddd.uab.cat/record/270592, https://dx.doi.org/urn:doi:10.1182/bloodadvances.2021006762